Piecewise HIV virus dynamic model with CD4 + T cell count-guided therapy: I

Journal of Theoretical Biology

Volumn 308, Issue , 2012, Pages 123-134

  Tang, Sanyi ^a   Xiao, Yanni ^b   Wang, Ning ^c   Wu, Hulin ^d  

^a SHAANXI NORMAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Durations of drug on and drug off; HAART; Mathematical model; Scheduled treatment interruption; Threshold window

Indexed keywords

ANTIVIRUS AGENT;

DISEASE TREATMENT; DRUG PRESCRIBING; HUMAN IMMUNODEFICIENCY VIRUS; NUMERICAL MODEL;

ARTICLE; CD4 LYMPHOCYTE COUNT; DYNAMICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MORBIDITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIMULATION; TREATMENT OUTCOME;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COMPUTER SIMULATION; HIV; HIV INFECTIONS; HUMANS; MODELS, IMMUNOLOGICAL;

EID: 84862705226     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2012.05.022     Document Type: Article

References (42)

1. Adams B.M., Banks H.T., Kwon H.D., Tran H.T. Dynamic multidrug therapies for HIV: optimal and STI control approaches. Math. Biosci. Engin. 2004, 1(2):223-241.
2. Ananworanich J., Nuesch R., Le Braz M., et al. Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS 2003, 17:F33-F37. 10.1097/01.aids.0000088241.55968.65.
3. Ananworanich J., Gayet-Agernon A., Le Braz M., et al. CD4 guided scheduled treatment interruption compared to continuous therapy: results of the Staccato Trial. Lancet 2006, 368:459-465.
4. Ananworanich J., Hirscel B. Intermittent therapy for the treatment of chronic HIV infection. AIDS 2007, 21:123-124.
5. Barreiro P., de Mendoza C., Gonzalez-laboz J., Soriano V. Superiority of protease inhibitors over nonnucleoside reverse-transcriptase inhibitors when highly active antiretroviral therapy is resumed after treatment interruption. Clin. Infect. Dis. 2005, 41:897-900.
6. Bernardo M.D., Budd C.J., Champneys A.R., et al. Bifurcations in nonsmooth dynamical systems. SIAM Rev. 2008, 50:629-701.
7. Blower S.M., Gershengorn H.B., Grant R.M. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 2000, 287:650-654.
8. Boukal D.S., Krivan V. Lyapunov functions for Lotka-Volterra predator-prey models with optimal foraging behavior. J. Math. Biol. 1999, 39:493-517.
9. Buchbinder S.P., Katz M.H., Hessol N.A., O'Malley P.M., Holmberg S.D. Long-term HIV-1 infection without immunologic progression. AIDS 1994, 8:1123-1128.
10. Chun T.W., Carruth L., Finzi D., et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387:183-188.
11. Costa M.I.S., Meza M.E.M. Application of a threshold policy in the management of multispecies fisheries and predator culling. IMA Math. Med. Biol. 2006, 23:63-75.
12. Danel C., Moh R., Minga A., et al. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. Lancet 2006, 367:1981-1989.
13. Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts <200cells/μl. AIDS 2008, 22:237-247. DART Trial Team.
14. Dercole F., Gragnani A., Rinaldi S. Bifurcation analysis of piecewise smooth ecological models. Theor. Popul. Biol. 2007, 72:197-213.
15. Dybul M., Chun T.W., Yoder C., et al. Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters. Proc. Natl. Acad. Sci. USA 2001, 98:15161-15166.
16. El-Sadr W.M., Lundgren J.D., Neaton J.D., et al. CD4+ count-guided interruption of antiretroviral treatment. The strategies for Management of Antiretroviral Therapy (SMART) study group. N. Engl. J. Med. 2006, 355:2283-2296.
17. Filippov A.F. Differential Equations with Discontinuous Righthand Sides 1988, Kluwer Academic, Dordrecht.
18. Guerrero Fernandez M.L., Rivas P., Molina M., Garcia R., De Gorgolas M. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy. Clin. Infect. Dis. 2005, 41:390-394.
19. Hadjiandreou M.M., Conejeros R., Ian Wilson D. Long-term HIV dynamics subject to continuous therapy and structured treatment interruptions. Chem. Eng. Sci. 2009, 64:1600-1617.
20. Hadjiandreou M.M., Conejeros R., Wilson I. HIV treatment planning on a case-by-case basis. Inter. J. Biol. Life Sci. 2011, 7(3):148-157.
21. Hirschel B., Flanigan T. Is it smart to continue to study treatment interruptions?. AIDS 2009, 23:757-759.
22. Huang Y., Rosenkranz S.L., Wu H. Modelling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity. Math. Biosci. 2003, 184:165-186.
23. CD4 cell-monitored treatment interruptions in patients with a CD4 cell count >500cells/μl. AIDS 2005, 19:287-294. International Study group on CD4-monitored treatment interruptions.
24. Korobeinikov A. Global properties of basic virus dynamics models. Bull. Math. Biol. 2004, 66:879-883.
25. Kuznetsov Yu.A., Rinaldi S., Gragnani A. One parameter bifurcations in planar Filippov systems. Inter. J. Bif. Chaos 2003, 13:2157-2188.
26. Liang H., Miao H., Wu H. Estimation of constant and time-varying dynamic parameters of HIV infection in a nonlinear differential equation model. Annals of Applied Statistics 2010, 4:460-483.
27. Lori F., Maserati R., Foli A., et al. Structured treatment interruptions to control HIV-1 infection. Lancet 2000, 355:287-288.
28. Maggiolo F., Ripamonti D., Gregis G., et al. Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial. AIDS 2004, 18:439-446.
29. Maggioloa F., Airoldia M., Callegaro A., et al. CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART. AIDS 2009, 23:799-807.
30. Meza M.E.M., Bhaya A., Kaszkurewicz E. Threshold polices control for predator-prey systems using a control Lyapunov function approach. Theor. Popul. Biol. 2005, 67:273-284.
31. Montaner J., Harris M., Hogg R. Structured treatment interruptions: a risky business. Clin. Infect. Dis. 2005, 40:601-603.
32. Nowak M.A., May R.M. Virus Dynamics: Mathematical Principles of Immunology and Virology 2000, Oxford University Press.
33. Oxenius A., Price D.A., Gunthard H., et al. For the Swiss HIV cohort study 2002: stimulation of HIV-specific cellular immunity by structured treatment interruptions fails to enhance viral control in chronic HIV-1 infection. Proc. Natl. Acad. Sci. USA 2002, 99:13747-13752.
34. Park, K.Y., Chung, H.B., Chung, C.C., 2006. Analysis of treatment for HIV-infected patients considering CD4 T Cell Count in STI. SICE ICASE International Joint Conference 2006, October 18-21 in Bexco, Busan, Korea.
35. Perelson A.S., Nelson P.W. Mathematical Analysis of HIV-1 dynamics in vivo. SIAM Rev. 1999, 41:3-44.
36. Rong L., Feng Z., Perelson A.S. Emergence of HIV-1 Drug resistance during antiretroviral treatment. Bull. Math. Biol. 2007, 69:2027-2060.
37. Rong L.B., Perelson A.S. Modeling HIV persistence, the latent reservoir, and viral blips. J. Theor. Biol. 2009, 260:308-331.
38. Rosenberg E.S., Davidian M., Banksc H.T. Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection. Drug Alocoho. Depend. 2007, 88S:S41-S51.
39. Ruiz L., Paredes R., Gomez G., et al. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients. AIDS 2007, 21:169-178.
40. Tirelli U., Bernardi D. Impact of HAART on the clinical management of AIDS-related cancers. Eur. J. Cancer 2001, 37:1320-1324.
41. Tebas P., Henry K., Mondy K., et al. Effect of prolonged discontinuation of successful antiretroviral therapy on CD4R T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies. J. Infect. Dis. 2002, 186:851-854.
42. Utkin V.I., Guldner J., Shi J.X. Sliding Mode Control in Electro-mechanical Systems 2009, Taylor & Francis Group. second ed.